Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?, The Korean Journal of Pain, January 2017, Korean Pain Society (KAMJE),
DOI: 10.3344/kjp.2017.30.3.183.
You can read the full text:
Contributors
The following have contributed to this page
